Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents
- PMID: 19303391
- DOI: 10.1016/j.ab.2009.03.016
Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents
Abstract
The capacity of hydrophobic octadecyl (C18) and SDR HyperD materials to remove the combination of 1% (v/v) solvent (tri-n-butyl phosphate, TnBP) with 1% (v/v) nonionic detergents (Triton X-100 and Triton X-45) used for viral inactivation of plasma-derived polyvalent intravenous immunoglobulin G (IVIG) preparation has been evaluated. Efficient removal of TnBP (<10 ppm in IVIG preparation) was found at ratios of 0.5 g of C18/7 ml of IVIG and 0.22 g of dry SDR HyperD/7 ml of IVIG. Binding capacities of TnBP were greater than 140 mg/g of C18 and greater than 318 mg/g of dry SDR HyperD. Complete removal of Triton X-45 (<2 ppm) was obtained at ratios of 1g of C18/7 ml of IVIG and 0.44 g of dry SDR HyperD/7 ml of IVIG or above, corresponding to binding capacities in excess of 70 mg/g of C18 and in excess of 159 mg/g of dry SDR HyperD. Residual Triton X-100 was less than 30 ppm at a ratio of 4 g/14 ml of immunoglobulin G (IgG) for the C18 sorbent. Triton X-100 was less than 10 ppm when using SDR HyperD at a ratio of 0.66 g/7 ml of IgG, corresponding to a binding capacity of approximately 106 mg of Triton X-100/g of dry SDR HyperD. Good recoveries of IVIG were achieved in the effluent from both sorbents.
Similar articles
-
Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.Biologicals. 2007 Oct;35(4):349-53. doi: 10.1016/j.biologicals.2007.03.002. Epub 2007 Jul 26. Biologicals. 2007. PMID: 17656111
-
A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.Vox Sang. 2006 Jul;91(1):56-62. doi: 10.1111/j.1423-0410.2006.00772.x. Vox Sang. 2006. PMID: 16756602
-
Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products.Biologicals. 2000 Mar;28(1):29-32. doi: 10.1006/biol.1999.0236. Biologicals. 2000. PMID: 10799053
-
Purification of intravenous immunoglobulin G from human plasma--aspects of yield and virus safety.Biotechnol J. 2006 Feb;1(2):148-63. doi: 10.1002/biot.200500037. Biotechnol J. 2006. PMID: 16892245 Review.
-
[Viral inactivation of fresh frozen plasma].Ann Med Interne (Paris). 1997;148(4):311-4. Ann Med Interne (Paris). 1997. PMID: 9515098 Review. French.
Cited by
-
Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.Blood Transfus. 2021 Nov;19(6):467-478. doi: 10.2450/2021.0159-21. Epub 2021 Aug 4. Blood Transfus. 2021. PMID: 34369872 Free PMC article.
-
Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody.J Pharm Sci. 2020 Dec;109(12):3579-3589. doi: 10.1016/j.xphs.2020.09.014. Epub 2020 Sep 15. J Pharm Sci. 2020. PMID: 32946895 Free PMC article.
-
Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome.PLoS One. 2016 Apr 21;11(4):e0153573. doi: 10.1371/journal.pone.0153573. eCollection 2016. PLoS One. 2016. PMID: 27100624 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous